SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-021965
Filing Date
2019-04-17
Accepted
2019-04-17 16:38:14
Documents
5
Effectiveness Date
2019-04-17

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-8213_3defa14a.htm DEFA14A 33204
2 GRAPHIC g82133bci001.jpg GRAPHIC 75566
3 GRAPHIC g82133bci002.jpg GRAPHIC 112800
4 GRAPHIC g82133bci003.jpg GRAPHIC 44177
5 GRAPHIC g82133bci004.gif GRAPHIC 3641
  Complete submission text file 0001104659-19-021965.txt   359920
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38492 | Film No.: 19753410
SIC: 2834 Pharmaceutical Preparations